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INTRODUCTION
Mammalian Flavin-ContainingMonooxygenase (FMO, EC
1.14.13.8) is a flavoprotein,which oxygenatesa wide variety
ofstructurallydiversexenobioticscontainingsoft-
nucleophiles, predominantlynitrogen and sulfur(1). Most
metabolites formed by thisenzyme are biologically inactive
and can be easily excreted,however, some are potentially
carcinogenic or mutagenic(1). The catalytic cycleof FMO
involves reduction ofFAD by NADPH. After reductionby NADPH,
NADP+ remains bound to theenzyme providing it with a certain
amount of stabilization. Dioxygenis then bound at the4-alpha
position of the flavin creatinga hydroperoxy moiety at this
site (1, 2 and Fig.A). Therefore, subtrate isnot required
for flavin reductionor oxygen binding and compoundsprone to
oxidation via a peracidare extremely good substrates forthe
enzyme (1).The ability of FMO tooxygenate such a wide
variety of compounds isbecause any soft nucleophilewith
access to the active site is oxygenatedwith chemistry similar
to oxidation by organic peroxides(3). Consequently, secondary
and tertiaryamines,aswellas manysulfur-containing
chemicals, have been shownto be substrates for theenzyme
(1). However, there doappear to be some protein-mediated
constraints influencingaccess to the active site (4).For
example, chemicals whichpossess more than one chargedatom,2
example, chemicals which possess more thanone charged atom,
such as glutathione, are not substrates. The specificityof
FMO results from exlusion of non-substrate (endogenous amines
and thiols) from the active site (2,5).The only known
endogenous substrate of FMO is cysteamine, which is oxidized
to the disufide, cystamine. The physiological roleof FMO is
uncertain but it may be related to the formationof disufide
bonds during protein synthesis (6).
The FMO and P-450-dependentmonooxygenases share some
commonfeatures,suchaslocalizationinmicrosomes,
requirements for oxygen and NADPH and activity towardthe same
substrates (1). These similarities led to early skepticism
concerning the existence of FMO.Subsequent studies have
demonstrated a number of interesting differences betweenthese
monooxygenasesystems.VariousP-450genefamiliesare
inducible by xenobiotics suchas 3-methylcholanthrene (1A
family),phenobarbital(2Bfamily),ethanol(2Efamily),
peroxisome proliferators (4B family) and steroids(3A family)
(7). With the possible exception of steroids, FMOhas been
shown not to be inducible by exposure toany agent.In
addition, compared to P-450, FMOsare notoriously thermolabile
(1). Liver FMOs from a number of speciesare stimulated by
primaryalkyamines,suchasn-octylamine,whichisan
inhibitor of P-450 (1). Another interestingdifference relates
to the unusual kinetics of FMO,in which the binding of
substrate has no effect on turnover, making allsubstrates3
have equivalent Vax values.These differences have been
exploited in studies of the relativerole of these two systems
in the metabolism ofa particular xenobiotic (8-10).
Recently, the existence of multipleforms of FMO was
documented when the first extrahepaticFMO was purified and
charaterized from rabbit lung(11-13). It was found that lung
andliverFMOweremarkedlydistinctwithrespectto
physiochemical properties suchas thermostability, pH optima
and sensitivity to anionicdetergents. Lung and liver FMO also
were found to be immunochemically andcatalytically distinct
(14-16). The cDNA sequence anddeduced protein sequence showed
that rabbit lung and liverFMO are different gene products.
Interestingly,rabbitliverFMOdisplayedmuchgreater
similarity to pig liver FMO(87%) than to rabbit lung FMO
(56%) (17, 18), indicating thatdistinct lung and liver FMOs
evolved prior to speciation.In addition to rabbit, other
species which have beenshown to have distinct lungFMOs
include mouse, rat, guinea pig,hamster, sheep and monkey (19,
20). A recent study demonstratedfour different forms of FMO
(IA1,IB1,IC1 and ID1)in human(21). The human IB FMO
present in small amounts inlung, liver and kidney, is 85%
identical to the rabbit lungenzyme. The "lung" FMO is also
present in other rabbit tissuesincluding kidney and bladder.
RabbitFMOsindifferenttissuesmayberegulated
independently and have differentsubstrate specificities and
evidence exists forsex- and developmental-related differences4
(1). Unlike the well knowncharacteristic of the cytochromeP-
450dependentmonooxygenasesystems,FMOseemstobe
refractory to induction byexogenous chemicals.Previous
studieshaveshownthatFMOcould beregulated
developmentally, presumably throughalterations in hormonal
status (1, 22).
These studies, utilizing rabbittissues, were designed to
investigate for the mechanismsof developmental and hormonal
regulation of FMO.5
Figure A. Major steps in the catalyticcycle of mammalian
microsomal flavin-containingmonooxygenases. The
cycle is from Ziegler (1990) (2).Figure A.
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ABSTRACT
Flavin-containing monooxygenase (FMO) isnot induced by
xenobiotics but is regulated byendogenous factors including
the steroid hormones. During the31 day gestational period of
rabbit, the plasma levels ofprogesterone increase until mid-
gestationandthendeclinetonon-pregnantlevelsby
parturition, whereas, glucocorticoidslevels peak only at
parturition. It has been shownthat FMO is induced during
gestation in rabbit. Rabbit tissueswere collected throughout
gestation (0, 10, 15, 20, 25,28 and 31 day) and postpartum
(1, 7, 21 and 29 day). Microsomesand total RNA were prepared
fromeachtissue."C-DimethylanilineN-oxidaseinlung
increased with pregnancy andwas highest on days 15 and 31 of
gestation and declined after parturition.Immunoquantitation
by western blotting was consistentwith FMO activity; lung
protein levels were higheston the 15th and 31st day of
gestation. A rabbit lung FMOcDNA probe was used to quantify
FMO mRNA by northern blotting and showedthat mRNA levels were
also highest on the 15th and31st day of gestation. The
protein level, FMO activity andFMO mRNA expression in kidney
indicatethatkidneyFMOwasinducedatthetimeof
parturition presumably by glucocorticoids,whereas, lung FMO
may be regulated by both progesterone andglucocorticoids. No
evidence was observed fora sex differenceor change during
pregnancy in the level of FMO in bladder. Thissuggests that
the levels and activity of FMOare regulated by endocrine12
factors and controlled bygene expression in a tissue-specific
manner.13
INTRODUCTION
tilammalianflavin-containingmonooxygenase (FMO,EC
1.14.13.8) is a flavoprotein, which catalyzesthe oxygenation
of a large variety of nitrogen- andsulfur-containing drugs
and xenobiotics (1). Most of the metabolitesformed by this
enzyme are biologically inactive and easily excreted,however,
some are potentially carcinogenic or mutagenic(1). The only
known endogenous substrate of flavin-containingmonooxygenase
is cysteamine, which is oxidizedto the disulfide, cystamine.
The physiological role of FMO isuncertain but it may be
related to the formation of disulfidebonds during protein
synthesis (2)At least three different forms ofFMO exist in
rabbit (3-5). The cDNAsequence of rabbit lung and liver
confirm different gene productsthat are related with 56%
identity in amino acidsequence (6). The extrahepatic FMO is
also present in rabbit kidney and bladderand evidence exists
for sex- and developmental-related differences.A recent study
demonstrated four different forms ofFMO, (IA1, IB1, IC1 and
ID1)1 in human (7,8). The humanIB FMO, present in small
amounts in lung, liver and kidney, is85% identical to the
rabbit lung enzyme (8). Rabbit FMOs indifferent tissues may
beregulatedindependently and have differentsubstrate
specificities. FMO is not inducible byexogenous compounds but
is regulated by endogenousfactors like sex steroids and
This nomenclature has been suggestedby R.M. Philpot and
U.A. Meyer.14
glucocorticoids (9). The purpose of the presentstudy is to
examine the developmental regulation of the "lung"form of FMO
in maternal rabbit tissues.15
MATERIALS AND METHODS
ANIMALS
Timed-pregnant New Zealand white rabbitswere obtained from
the Rabbit Research Institute at Oregon StateUniversity and
housed in the Laboratory Animal Resource Center.Animals were
maintained on a 12-hour day-night cycle, andfeeding was ad
libitum. In order to follow the developmentalregulation of
the levels of FMO activity, protein levels andmRNA, a total
of 20 pregnant, 2 non-pregnant female and 2 malerabbits were
used. Two pregnant females were killedon days 10, 15, 20, 25,
28 and 31 of gestation. Following parturition,two rabbits
were killed on days 1, 7, 21 and 28 post-partum. Animalswere
killed byCO,asphxiation.Thetissues were immediately
removed and frozen in liquid nitrogen andstored at -90°C
until assayed.
MICROSOME PREPARATION
Microsomes were prepared usinga modification of the
procedure of Guengerich (10). The levels of microsomalprotein
were assayed by the method of Lowry et Al., (11) using BSA2
as the standard.
2Abbreviations used: BSA, bovineserum albumin; SDS-PAGE,
polyacrylamide gel electrophoresis in thepresence of
sodium dodecyl sulfate; PBS, 20 mM potassiumphosphate,
pH 7.4, 0.8% NaCl; IgG, immunoglobulin G;DMA, N,N'-
dimethylaniline; PCR, polymerase chain reaction;
20 X SSC, 3 M sodium chloride, pH 7.0, 0.3M sodium
citrate.16
IMMUNOQUANTITATION
The microsomal proteins were resolvedby SDS-PAGE and then
electrophoretically transferred to nitrocellulose.Following
1 hour incubation at room temperature with2% BSA in PBS, the
blots were stained with guinea pig anti-rabbitlung FMO IgG
(20 pig IgG per ml in 2% BSA-PBS buffer with0.05% Triton X-
100) for 1.5 hour at room temperature. TheFMO-IgG complexes
were visualized by incubating with [125I)-proteinA for 1 hour
followed byautoradiography(12).Immunoquantitation was
performed by laser densitometry and relativeamounts of FMO
were calculated utilizing the purified rabbitlung FMO as
standard forlungand relative densitiesof blots were
compared for kidney and bladder.
ASSAY OF FMO ACTIVITY
The metabolism of ["C]-DMA by microsomalFMO was performed
by HPLC to resolve the N-oxide andN-demethylated metabolites.
Microsomes (0.1 mg) or purified FMO(0.02 mg) were incubated
in 0.1 M tricine, pH 8.5 containing1 mM EDTA, and an NADPH
generating system [1 mM NADPH,0.02 M isocitrate and 1 Unit
isocitrate dehydrogenase].["C]-DMA was added toa final
concentration of 0.5 mM (1-2 pCihimol). All components,
except the microsomes or purifiedFMO, were preincubated for
2 min and the reaction initiated bythe addition ofenzyme.
The reaction was terminated by theaddition of 0.1 ml of
methanol. HPLC analysis was performed witha Whatman RAC II17
Partisil 5 ODS-3 (4.6mm x 10 cm) column eluted with 62% Me0H
in water at 0.5 ml/min.Metabolite quantitationwas performed
with an on-line radiochemicaldetector (Beckman Model 171,
equipped with a solid cell).
RNA ISOLATION
Total RNA were prepared bythe modified method of acid
guanidinium thiocyanate-phenol-chloroformextraction (13).
RABBIT LUNG cDNA (1643 bp)PREPARATION
To obtain a cDNA, 1pg of the female (28 day gestation)lung
mRNA was used as a template tomake a lung library. Oligo (dT)
wasusedasaprimeralongwithsuperscriptreverse
transcriptase enzyme underthe conditions recommendedby
Gibco/BRL. One-fifth of thetotal cDNA was then used ina PCR
reaction.UtilizingtherabbitlungFMOcDNAsequence
published by Lawton et al.(6), we employed primersequences
from 67 to 94 and from 1683to 1710, respectively. Theentire
coding region was amplifiedin a fragment of 1643 bp.The DNA
in the PCR reactionwas treated with T4 DNA polymeraseto
ensure the presence of blunt ends,then fractionated onan
agarose gel, the 1643 by band excisedand eluted using glass
milk. The DNA was thenligated with Smal-digested,CIAP-
treated pUC19 which was thenused to transform E. coliDH5a.
The fragment was oriented inthe plasmid opposite to 0-
galactosidase. The intactcDNA fragments were excisedfrom18
pRNH135 utilizing EcoRI andBamHI digestion.
ELECTROPHORESIS AND TRANSFER
Electrophoresis of RNA throughagarose-containing formaldehyde
was performed by published procedures(14). The amount of RNA
in each sample was measuredby optical density at260 and 280
nm; 20 pg of each samplewas analyzed through agarose gel
containing formaldehyde induplicate. RNA in the gelwas
transferred to nylon membraneby capillary movementovernight
using 20 X SSC buffer andthe transferred blotwas exposed to
UV light (U.V. Crosslinker,XL-1000, Fisher Biotech) to fix
the RNA on the membrane(15).
HYBRIDIZATION
A probe used to quantifyrabbit lung FMO mRNAon northern
blots was obtained byrandom primer-labeling ofrabbit lung
FMO cDNA (1643 bp) with a32P-dCTP(16). After prehybridization
for 4 h in 6 X SSC, 50%formaldehyde, 0.1% SDS, 5 XDenhardt's
solution,100 µg /ml salmonsperm DNA and 100 µg /ml tRNA,
hydbidization was performedat 42°C overnight in thesame
medium in the presence ofcDNA labeled with [a-32P]dCTP(ICN)
with a random primer-labelingkit from Boehringer Mannheim.
The filter was washed in2 X SSC buffer containing0.1% SDS
twice at room temperaturefor 15 min and 0.1 X SSCbuffer with
0.1% SDS at room temperaturefor 15 min. The membranewas then
exposed to Kodak X-OMAT AR film(Kodak, Rochester, NY) for319
days with an amplifyingscreen at -90°C. Integrity of RNAwas
routinely assessed witha 0-actin cDNA probe to demonstrate
that each lane containedapproximately equal amounts ofmRNA.20
RESULTS AND DISCUSSION
Little work has beenpublished on the hormonalregulation
of FMO. Sex-related differencesin the concentrationor enzyme
activity of FMO havebeen observed in rats, mice,and rabbits
(17). During late gestation,changes in the hormonal milieu
appear to be responsible forFMO induction in rabbitlung
(3,18).
The regulation of rabbitFMO throughout gestationand
postpartum has been followedin maternal lung, kidneyand
bladder utilizingimmunoquantitation with antibodyto lung
FMO. In a previous report,it was found that rabbitlung FMO
is maximumally inducedon day 28 of gestation anddecreased
post-partum (3,19). In thisstudy, the peak levels oflung
protein were observedat mid- and late-gestation,whereas, the
protein peak in kidneywas at the time of parturition(Figs.
1.1A,1.1B,1.2).Noevidence was observedforasex
difference or change duringpregnancy in the level of protein
in rabbit bladder (Figs.1.2, 1.9A, 1.98). Themeasurement of
enzymatic activity inlung, kidney and bladderwas consistent
with protein levelsduring pregnancy (Fig.1.3).Rabbit lung
FMO is higher in adultfemale rabbits comparedto males
(Fig.1.4) and this isconsistent with the resultsof previous
studies (3,18-20). Thekidney FMO expressionwas slightly
higher in adult femalesthan in adult males(Fig.1.4). This is
in contrast toa previous study where kidneyFMO expression in
males was higher thanthat of females (3).To examine the21
levelsofFMO mRNA expressedinmaternallungduring
gestation, total RNAwas isolated from lungs ofrabbits killed
at various times ofgestation and postpartum.The levels of
mRNA quantitated bynorthern and slot blottingusing 32P-
labeled rabbit lungFMO cDNA were significantlyincreased
throughout gestationand two peakswere observed at mid-
gestation and at thetime of parturition(Figs. 1.5A, 1.5B).
The levels of FMOmRNA decline afterparturition to levelsat
or below those in virginfemales. Peaks of lungFMO mRNA
during mid- andlate-gestation are consistentwith protein
levels (Figs. 1.1,1.5). The mid-gestationpeak corresponds to
the peak of progesteronelevels in the rabbit,and the peak
during late-gestationis consistent withglucocorticoid levels
(21, Fig. 1.6) andthe serum levels ofcorticosteroid-binding
globulin duringpregnancy (22). Therefore, suggestiveevidence
existsforhormonalregulationofrabbitlungFMO
transcription duringpregnancy and post-partumalthough other
mechanisms suchas increased mRNA stabilitycan not be ruled
out. FMO mRNA levelsin rabbit kidneywere significantly
increased duringlate-gestation, but notat mid-gestation
(Figs. 1.8A, 1.8B).The pattern of kidneyFMO mRNA expression
is consistent withthat of protein levelsand activity during
gestation (Figs.1.2, 1.3, 1.7, 1.8).This result suggests
that FMO in kidney isnot influenced byprogesterone but may
beregulatedby glucocorticoidswhich reachapeakat
parturition(21,Fig.1.6).Another current studyin our22
laboratory involving hormoneimplantation or injection to
rabbits,supportstheseresults.Bothprogesteroneand
dexamethasone induced FMO in malerabbit lung, whereas, only
dexamethasone induced FMO inmale rabbit kidney. Estradiol
could induce FMO in femalerabbit lung but not in male(M.-Y.
Lee et.al., unpublished).
The results presented hereconfirm the dominant roleof
hormonal regulation in thecontrol of FMO, but the effects
observed appear to besex- and tissue-dependent.23
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Figure 1.1.Western blots of rabbitlung FMO throughout
gestation probed withguinea pig anti-rabbitlung
FMO IgG (A) and quantitationof rabbit lung FMO
throughout gestation(B).
(A) Rabbit lung microsomes(each sample contained
10 mg of microsomalprotein) were
electrophoretically transferredfrom SDS-PAGE to
nitrocellulose. Thenitrocellulose was
immunostained with guineapig anti-rabbitlung
FMO IgG (20 mg/ml)followed by "15I-proteinA as
decribed by Burnette(12). (B) The valuesshown
were obtained usingdensitometry from
autoradiograms of westernblots. * *-
Statistically significantcompared to non-
pregnant female (Student'st test, p<0.05).Each
value represents themean of two rabbits.Figure 1.1A.
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Figure 1.2.FMO levels in differenttissues of pregnant
rabbits throughout gestation.The relative amount
of FMO in lung, kidney andbladder during
pregnancy and post-partumwere compared, with
densitometry of western blotsusing the antibody
to rabbit lung FMO. Valuesrepresent the mean of
2 rabbits.VO e\1696\k.:\ssues o.kegr\of\ eref\ oNobik_s
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Figure 1.3. 14C-N,N-DimethylanilineN-oxidation by microsomes
in different tissues of rabbitsduring pregnancy
and post-partum. The relativeactivities of FMO in
lung, kidney and bladder duringpregnancy and
post-partum were compared. Each valuerepresents
the mean of duplicateassays of 2 different
animals.4
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Figure 1.4. FMO levels in tissuesof male and non-pregnant
female. The relative amount ofimmunoreactive FMO
was determined using antibody to lungFMO and
densitometry from the westernblots. Protein
concentrations of male lung, kidneyand bladder
were compared to those of non-pregnantfemales.
Values represent the mean of2 rabbits.30
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Figure 1.5. Northern blotsand slot blots of rabbit lungFMO
throughout gestation (A) andquantitation of
rabbit lung FNO mRNA expression(B). (A) Total RNA
isolated from rabbit lungwas analyzed by northern
and slot blotting with 32P-labeledrabbit lung FMO
cDNA. The slot blot was subsequentlyreprobed with
a human fibroblast A-actin cDNA toassess the
relative amounts of RNAanalyzed in each sample.
(B) The data are produced usingthe densitometry
of autoradiograms of totalRNA northern blots.
Lane 1, male; lane 2, non-pregnantfemale; lane 3,
10 day; lane 4, 15 day; lane5, 20 day; lane 6,
aborted; lane 7, 25 day; lane8, 28 day; lane 9,
31 day pregnancy; lane 10,7 day; lane 11, 21 day;
lane 12, 29 day post-partum.Each lane contained
20 lig total RNA. Values representthe mean of 2
rabbits.Figure 1.5A.
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Figure 1.6. Peripheralplasma levels of progesterone,cortisol
and coticosterone in rabbitduring pregnancy.
Adapted from Baldwin atal., (21).Plasma hormone levels In pregnant rabbits
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Figure 1.7. Westernblots of rabbit FMO inkidney throughout
gestation probed withguinea pig anti-rabbitlung
FMO IgG (A) and quantitationof FMO in kidney
throughout gestation(B).
(A) Rabbit kidneymicrosomes (50 pg protein)were
electrophoretically transferredfrom SDS-PAGE to
nitrocellulose. Thenitrocellulose was
immunostained with guineapig anti-rabbit lungFMO
IgG (2011g/m1) followedby 125I-protein Aas
described by Burnette(12). lane 1, male; lane2,
non-pregnant female; lane3, 10 day; lane 4, 15
day; lane 5, 20 day;lane 6, 25 day; lane7, 28
day; lane 8, 31 dayof gestation; lane 9,1 day;
lane 10, 7 daypostpartum. (B) Valuesshown were
obtained using densitometryfrom autoradiograms of
western blots. * *- Statistically significant
compared to non-pregnantfemale (student's t test,
p<0.05). Each valuerepresents the mean of2
rabbits.39
Figure 1.7A.
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Figure 1.8. Northern blotsof rabbit FMO in kidneythroughout
gestation (A) and quantitationof rabbit mRNA
expression in kidney (B).(A) Total RNA isolated
from rabbit kidneywas analyzed by northern
blotting with 32P- labeledrabbit lung FMO cDNA.
Lane 1, male; lane 2, non-pregnantfemale; lane 3,
10 day; lane 4, 15 day; lane5, 20 day; lane 6, 25
day; lane 7, 28 day; lane8, 31 day pregnancy;
lane 9, 1 day; lane 10,7 day post-partum. Each
lane contained combined20 pg total RNA of 2
rabbits. The blotwas subsequently reprobed with
a human fibroblast P-actin cDNA(32P-labelled) to
assess the relative amounts ofRNA analyzed in
each sample. (B) The dataare produced using
densitometry of autoradiogramsfrom northern
blots.42
Figure 1.8A.
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Figure 1.9. Westernblots of rabbit FMO inbladder throughout
gestation probed with guineapig anti-rabbitlung
FMO IgG (A) and quantitationof FMO in bladder
throughout gestation (B).
(A) Rabbit bladdermicrosomes (50 pg protein)were
electrophoretically transferredfrom SDS-PAGE to
nitrocellulose. The nitrocellulosewas
immunostained with guineapig anti-rabbit lungFMO
IgG (20µg /ml) followedby 125I-protein Aas
described by Burnette(12). Lane 1, male; lane2,
non-pregnant female; lane3, 10 day; lane 4,15
day; lane 5, 20 day;lane 6, 25 day; lane7, 28
day; lane 8, 31 daypregnancy; lane 9, 1 day; lane
10, 7 day; lane 11,21 day; lane 12, 29 daypost-
partum; lane 13, abortedat 21 day. (B) Thedata
are produced using densitometryof autoradiograms
from western blots andeach value representsthe
mean of 2 rabbits.Figure 1.9A.
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ABSTRACT
Unlikethemuch-studiedcytochromeP-450-dependent
monooxygenasesystem,mammalianmicrosomalFMOisnot
inducible by xenobiotics, butdoes appear to be regulated
developmentally, presumably throughalterations in hormonal
status. It isbelievedthatenzymeinductionby
glucocorticoids is mediated byspecific cell receptors. The
number of glucocorticoid-specificnuclear binding sites in
rabbit fetallung increases during thelast10 days of
gestation, a process whichcorrelates with increased levelsof
pulmonary surfactant and risinglevels of cortisol in the
fetal circulation. Coricosteroidsinduce specificenzymes in
many tissues such as the embryonic retina,fetal gut, and
newborn liver. The levels of rabbitfetal and neonatal FMO
have been followed from day15 fetuses to day 29 neonatesby
assaying enzyme activity, proteinlevels (western blotting)
and mRNA levels (northern blottingwith 32P-labeled rabbit lung
cDNA). Fairly high levels ofFMO are found in fetal rabbit
lung and liver at 25 days and continueto rise until birth at
which point the levelsare about 60% that of the adult. The
levels continue to rise after birthto adult levels by 3 weeks
of age. The results of thisstudy indicate that FMO isunder
developmental and hormonal control,possibly at the level of
transcription. Alterations ofFMO activity in pregnancyor
early development are importantfor study given the role that
FMO plays in the metabolism offoreign drugs.52
INTRODUCTION
Flavin-containingmonooxygenase(FMO)catalyzesthe
oxygenation of a great numberof xenobiotics containinga soft
nucleophilic substituent, usuallya nitrogen or sulfur atom
(1).Unlikethemuch-studiedcytochromeP-450-dependent
monooxygenasesystem,mammalianmicrosomalFMOisnot
inducible by xenobiotics,but does appear to be regulated
developmentally, presumably throughalterations in hormonal
status (2). A current study inthis laboratory indicatesthat
the activity and level of proteinand mRNA of rabbit FMO could
bedevelopmentallyregulatedthroughoutgestationand
progesterone and glucocorticoidsappear to be involved, but
the mechanisms might betissue-specific. It is believedthat
enzyme induction by glucocorticoids ismediated by specific
cellreceptors.Anumberofobservationsindicatethat
glucocorticoids mayplayanimportantrole duringlung
maturation and biochemicaldifferentiation. Administrationof
exogenous glucocorticoids to mammalianfetuses at appropriate
stages of gestation acceleratesmorphological development of
thelungandcauses precociousappearanceofpulmonary
surfactant (3-6).
In addition, endocrine ablation,such as decapitation ofrat
fetuses, results in inhibitionof normal lung maturationand
decreasedlevelsofsurfactantinfetallungs(7).A
deficiencyofsurfactantinlungofhumaninfantsis
considered to be the primarycause of respiratory distress53
syndrome, a major cause of deathin premature infants (8).It
is generally believedthat the first step in thecellular
action of steroid hormonesinvolves the interaction of the
hormone with specific cytoplasmicreceptors (9). The steroid
receptor complex then migratesto the nucleus, where it binds
to specific acceptor siteson the chromatin (9-11). Asa
result of this interaction,the transcriptional apparatus is
activatedtoproducespecificRNAandfinallyyield
appropriateproteins.Rabbitfetallungnucleicontain
macromolecules which have theproperties of physiological
receptors for glucocorticoids whichmay exert their effects by
inducing thesynthesisofkeyenzymesinvolvedin the
biosynthesis of the phospholipidcomponents of surfactant
(12). The increase in concentrationof nuclear binding sites
between day 20 and day 28of gestation correlates with
reported changes in pulmonaryepithelial cell maturation and
surfactant concentrations inlung extracts and evidence for
the presence of cytoplasmiccortisol-binding components in
fetal lung was also presented(12).Another report also
demonstrated specific bindingof dexamethasone in fetal lung
extracts.Thisreportalso describes theisolation and
properties of macromolecular-glucocorticoidcomplexes
extracted from the cytosol fractionsof fetal lung and fetal
liver (13). Glucocorticoidspromote fetal maturation (14)and
changes in plasma corticosteroid-bindingglobulin (CBG) levels
undoubtedly influence glucocorticoidbioavailability during54
critical stages of development(15).
Two forms of liver FMO hasbeen isolated from guinea pig
and rabbit (16, 17) andtwo human liver FMO cDNAshave been
sequenced (18). The major formin rabbit liver (form I) is87%
identical to the pigliverform and formIinhuman.
Interestingly, FMO form Iis present in onlyvery small
amounts in adult human livers,but is present in fetal liver.
The major form in adult humanliver is 85% identical torabbit
liver form II. Littleor nothing is known of thedevelopmental
regulation of rabbit formsIand II.The only antibody
available for this study isthe one raised against pigliver
(form I).
The purpose of this studyis to examine developmental
regulation of FMO in fetaland neonatal rabbit lung andliver
tissue which seems to beunder developmental andhormonal
control, possibly at the levelof transcription.55
MATERIALS AND METHODS
ANIMALS
Timed-pregnant New Zealand whiterabbits were obtained from
the Rabbit Research Instituteat Oregon State University and
housed in the Laboratory AnimalResource Center. Animalswere
maintained on a 12-hour day-nightcycle (7 AM - 7 PM), and
feeding was ad libitum.In order to follow the developmental
regulation of the levels ofFMO activity, protein and mRNA,
fetaland neonatalrabbits were used.Thefetuses were
sacrificed on days 20, 25,28 and 31 of gestation. Following
parturition, two neonatal rabbitswere euthanized on days 1,
15,22 and 29 after birth. Animalswere euthanized by CO,
asphxiation. The tissueswere immediately removed and frozen
in liquid nitrogen andstored at -90°C until assayed.
MICROSOME PREPARATION
Microsomes were prepared usinga modification of the
procedure of Guengerich (19). Thelevels of microsomal protein
were assayed by the method of Lowrygt al., (20) using BSA'
as the standard.
'BSA, bovine serum albumin;SDS-PAGE, polyacrylamide gel
electrophoresis in thepresence of sodium dodecyl sulfate;
PBS, 20 mM potassium phosphate,pH 7.4, 0.8% NaCl; IgG,
immunoglobulin G; DMA,N,N'-dimethylaniline.56
IMMUNOQUANTITATION
The microsomal proteinswere resolved by SDS-PAGE and then
electrophoretically transferred tonitrocellulose. Following
an 1 hour incubation at room temperaturewith 2% BSA in PBS,
the blots were stained with eitherguinea pig anti-rabbit lung
FAO IgG or rabbitanti-pig liver FMO IgG (20pg IgG per ml in
the 2% BSA-PBS buffer with 0.05%Triton X-100) for 1.5 hourat
room temperature. The FMO-IgG complexeswere visualized by
incubating with [125I]-proteinA (0.1 pCi/m1 in 2% BSA-PBS
buffer) followed by autoradiography(21). Immunoquantitation
was performed by laser densitometry.The relative amounts of
FMO were calculated utilizingthe purified rabbit lung FMOas
standard for lung and relativedensities of blotswere
compared for liver.
ASSAY OF FMO ACTIVITY
The metabolism of ["C] -DMA bymicrosomal FMO was performed
by HPLC to resolve the N-oxideand N-demethylated metabolites.
Microsomes (0.1 mg)or purified FMO (0.02 mg) were incubated
in 0.1 M tricine, pH8.5 containing 1 mM EDTA, andan NADPH
generating system [1 mM NADPH,0.02 M isocitrate and 1 Unit
isocitrate dehydrogenase].["C]-DMA was added toa final
concentration of 0.5 mM (1-2pCiAlmol). All componentsexcept
the microsomes or purifiedFMO were preincubated for 2 minand
the reaction initiated bythe addition of enzyme. The reaction
was terminated by the addition of0.1 ml methanol. HPLC57
analysis was performed witha Whatman RAC II Partisil 5 ODS-3
(4.6 mm x 10 cm) column eluted with62% Me0H in water at 0.5
ml/min. Metabolite quantitationwas performed with an on-line
radiochemical detector (Beckman,Model 171 equipped witha
solid cell).
RNA ISOLATION
Total RNA was prepared bythe modified method of acid
guanidinium thiocyanate-phenol-chloroformextraction (22).
RABBIT LUNG cDNA (1643 bp)PREPARATION
To obtain a cDNA, 1 pg of thefemale (28 day gestation) lung
mRNA was used as a template tomake total cDNA. Oligo (dT)was
used as a primer along withsuperscript reverse transcriptase
enzyme under the conditions recommendedby Gibco/BRL. One-
fifth of the total cDNAwas then used in a PCR reaction.
Utilizing the rabbit lungcDNA sequence done by Lawton etal.
(23), we selected the primers tobe from 67 to 94 and from
1683 to 1710, respectively. Notethat the entire coding region
has been amplified ina fragment of 1643 bp. The DNA inthe
PCR reaction was treated withT4 DNA polymerase toensure the
presence of blunt ends, then fractionatedon an agarose gel,
the 1643 by band excised andeluted using glass milk. TheDNA
was then ligated with Smal-digested,CIAP-treated pUC19 which
was then used to transform E. coliDH5a. The fragment was
oriented in the plasmid oppositeto 0-galactosidase. The58
intact cDNA fragmentswere excised from pRNH135 utilizing
EcoRI and BamHI digestion.
ELECTROPHORESIS AND TRANSFER
Electrophoresis of RNA throughagarose containing formaldehyde
was performed by published procedures (24). Theamount of RNA
in each sample was measured byoptical density at 260 and 280
nm; 20 lig was analyzed by electrophoresis induplicate. RNA in
the gel was transferred tonylon membrane by capillary
movement overnight using 20 XSSC buffer and the transferred
blot was exposed on UV light (UVCrosslinker, XL-1000, Fisher
Biotech) to fix the RNAon the membrane (25).
HYBRIDIZATION
The probe, used to quantitaterabbit lung FMO mRNA on northern
blots, was obtained by random primer-labelingof rabbit lung
FMO cDNA (1643 bp) with a32P-dCTP (26).After prehybridization
for4hour in6X SSC,50% formaldehyde,0.1% SDS,5 X
Denhardt's solution, 100 pg/ml salmonsperm DNA and 100 µg /ml
tRNA, hydbidization was performedat 42 °C overnight in the
same medium in the presence of cDNA labeled with[a-32P]dCTP
(ICN)byarandomprimer-labelingkitfromBoehringer
Mannheim. The filterwas washed in 2 X SSC buffer containing
0.1% SDS twice at room temperaturefor 15 min and 0.1 X SSC
buffer with 0.1% SDS atroom temperature for 15 min. The
membrane was then exposed toKodak X-OMAT AR film (Kodak,59
Rochester, NY) for 6 days withan amplifying screen at -90°C.
Integrity of RNA was routinelyassessed with a 3210-0-actin cDNA
probe to demonstrate that each lanecontained approximately
equal amounts of RNA.60
RESULTS AND DISCUSSION
In fetuses and neonatal rabbits,there was a significant
development of FMO protein, activityand mRNA expression in
lung (Figs.2.1, 2.2). A specificcontent of 0.8 nmol FMOper
mg protein would represent 5%oftotallung microsomal
protein. The fetal (sexundetermined) lung FMO levelswere
readily detectable at day25 and rose steadly until birth.The
protein levels continued toincrease until day 15 (about0.51
nmol/mg) after birth at which pointthe levels are about 80%
that of the adult and thendecreased slightly,showing
unexpectedly low values at day22 after birth. Perhaps the
ratio of males to femaleswas higher at day 22 than other
groups. The fetal lung FMO mRNA expressionbetween day 20 and
parturition increased bymore than two-fold (Figs. 2.3, 2.4).
DMA N-oxidase activity in lungmicrosomes began to increaseat
3 days before birth in fetus andcontinued to increase after
birth until activity at day29 after birth was near the adult
levels (Fig. 2.5).
The western blot shown in Figure2.6 indicates that the
antibody to pig liver FMO(form I) cross-reacted withmore
thanasingle bandfrom rabbitliver,especially with
microsomes from fetal andneonatal rabbits. It is not possible
at this time to separatelyquantitate rabbit liver FMOforms
I and II, as no antibodiesare available. These enzymes differ
in molecular weight byonly about 500 daltons andare very
difficult to resolve bySDS-PAGE. Therefore, for thepurposes61
of this study, the major band in fetal andnoenatal liver
microsomes was quantified withno conclusion as to the number
of forms or their identities.
The hepatic FMO protein levels also startedto increase
before birth and continued to increase after birthand the
level of protein at day 29 after birthwas above the adult
levels (Figs. 2.6, 2.7). DMA N-oxidase activities infetal
livermicrosomesincreasedsteeplyfromday25-31and
continued to increase in neonates until day29 (except on day
15). Activities of both 31 day fetuses and 29day neonates
were near those of the adults (Fig. 2.8).
A current study in this laboratory has shownthat the
activity and the level of protein andmRNA of rabbit FMO could
bedevelopmentlyregulatedthroughoutgestationand
progesterone and glucocorticoidswere implicated, but the
mechanisms might be tissue-specific (Lee gt., unpublished).
Both the plasma level of glucocorticoids andcorticosteroid-
binding globulin during pregnancy reacha peak at the time of
parturition (27, 28). According to the results withfetal lung
shown above, the degree of FMO increase before birthis rapid
and correlates to the peak of plasma glucocorticoidlevels at
parturition(Fig.2.9).Thisresultindicates that FMO
inductioninfetallungbeforebirthmaybeunder
developmental and hormonal control by glucocorticoids,perhaps
at the level of transcription. This is supportedby previous
reports that glucocorticoids playan important role during62
lung maturation and biochemicaldifferentiation(27)and
administration ofexogenous glucocorticoids to mammalian
fetusesatappropriatestagesofgestationaccelerates
morphological development of the lungand causes precocious
appearance of pulmonary surfactant (3-6).
A number of hormones and enzymes whichare important in
metabolismaresubjecttoregulationbytheratioof
cysteamine/cystamine(29).FMO ispresent in endoplasmic
reticulum at the site of protein synthesis,and could provide
oxidizingequivalentsidealforpeptidedisulfidebond
formation and the oxidation of cysteamineto cystamine by FMO
could be a potential source of cellulardisulfide (29).
Rabbit fetal lung nuclei containmacromolecules which have
the properties of physiological receptorsfor glucocorticoids
which may exert their effects by inducingthe synthesis of key
enzymes involved in the biosynthesis ofthe phospholipid
components of surfactant (12). The increasein concentration
of nuclear binding sites during lategestation, resulting in
pulmonaryepithelialcellmaturationandsurfactant
concentrations in lung extracts (12),correlates with fetal
lung FMO induction before birth andsuggests an involvement in
protein-disulfide bond formation forthe structural function
of protein especially for fetal andneonatal animals.63
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Figure 2.1. Western blot analysis offetal and neonatal rabbit
lung microsomes probed with guineapig anti-rabbit
lung FMO IgG and comparison toadult levels. lane
1, adult male; lane 2, adultnonpregnant female;
lane 3, 25 day fetus; lane 4, 28 dayfetus; lane
5, 31 day fetus; lane 6, 1 dayneonate; lane 7, 15
day neonate; lane 8, 22 dayneonate; lane 9, 29
day neonate. Each lane contained50 pg protein.Figure 2.1.
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Figure 2.2. Quantitationof rabbit lung FMO infetuses and
neonates and comparison toadult levels. The
values shown were obtainedusing densitometry of
autoradiograms of westernblots of 2 different
gels (Fig.2.1) probed withguinea pig anti-rabbit
lung FMO.1500
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Figure 2.3. Northern blot analysisof fetal and neonatal
rabbit lung total RNA andcomparison to adult
levels. RNA was probed with"P-labelled rabbit
lung FMO cDNA. lane 1, adultmale; lane 2, adult
nonpregnant female; lane 3, 20 dayfetus; lane 4,
25 day fetus; lane 5, 1 dayneonate. Each lane
contained 20 lig total RNA.Figure 2.3.
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Figure 2.4. Fetal and neonatal rabbitlung FMO mRNA expression
with rabbit lung FMO cDNAprobe. The graph was
produced using a densitometry fromnorthern blots
(Figure 2.3) of 2 different gels.2E4
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Figure 2.5. "C-N,N-dimethylanilineN-oxidation by fetal and
neonatal rabbit lung microsomesand comparison to
adult levels. Each valuerepresents the mean of
duplicates from 2 differentanimals.74
Figure 2.6. Western blotanalysis of fetal andneonatal rabbit
liver microsomes probedwith rabbit polyclonal
antibody to pig liverFMO and comparison toadult
levels. lane 1, 20 plstandard of pig microsomes
from OXYgene (Dallas)Western Blot Kit; lane2,
male; lane 3, nonpregnantfemale; lane 4, 25 day
fetus; lane 5, 28 day fetus;lane 6, 31 day fetus;
lane 7,8, 1 day neonate;lane 9,10, 15 day
neonate; lane 11, 22 dayneonate; lane 12, 29 day
neonate. Each lane contained50 pg protein except
the standard.Figure 2.6.
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Figure 2.7. Quantitation offetal and neonatal rabbit liver
FMO and comparison to adultlevels. The values
shown were obtained using densitometryfrom
autoradiograms of western blots(Fig.2.6) of 2
different gels probed with antibodyto pig liver
FMO.DEVELOPMENT OF RABBIT LIVER FMO IN FETUS AND NEONATE
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Figure 2.8. "C-DMA N-oxidationby fetal and neonatal rabbit
liver microsomes and comparisonto adult levels.
Each value represents themean of duplicate assays
from 2 different animals.c
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Figure 2.9. Peripheral plasma levelsof progesterone, cortisol
and corticosterone in rabbitduring pregnancy and
correlation of fetal lungand liver FMO with
maternal plasma cortisollevels. Adapted from
Baldwin et al., (1974) (27).10
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ABSTRACT
UnlikethecytochromeP-450-dependentmonooxygenase
system,mammalianmicrosomalFMOisnotinducibleby
xenobiotics, but doesappear to be regulated developmentally,
presumablythroughalterationsinhormonalstatus.FMO
activity is influenced bysome nutritioal factors suchas
starvation, ascorbic aciddeficiency and diabeticdisease.
Previous study showed thatthe levels of rabbitlung FMO
during pregnancy were inducedat mid- and late-gestationwhich
correlates to the peak of plasmalevels of progesterone and
glucocorticoids, respectively,throughout gestation. TheFMO
in kidney was significantlyincreased during late-, butnot
mid-gestation, suggesting thatFMO in kidney is not influenced
by progesterone butmay be regulated by glucocorticoidswhich
peak at parturition. Subcutaneous injection with
dexamethasone,progesterone,estradiol,aldosteroneand
estradiol plus progesteroneto male rabbits,resulted in
progesterone and dexamethasone bothsignificantly inducing
lung FMO at the level of proteinand mRNA. In kidney, only
dexamethasone increased FMO.Intraperitoneal implantationof
hormone capsules with estradioland progesterone in female
rabbits resulted in bothestradiol and progesteroneinducing
lung FMO. These data supportthe hypothesis that rabbit"lung"
FMO is developmentlly regulatedand progesterone, estradiol
and glucocorticoidsare involved, but the mechanismsmay be
tissue-and sex-specific.87
INTRODUCTION
Mammalianflavin-containingmonooxygenase (FMO,EC
1.14.13.8) is a flavoprotein, whichcatalyzes the oxygenation
of a large variety of nitrogenand sulfur-containing drugs and
xenobiotics (1). Most of themetabolites formed by thisenzyme
are biologically inactive andcan be easily excreted, however,
some are potentially carcinogenicor mutagenic (1). The only
known endogenous substrate offlavin-containing monooxygenase
is cysteamine, which is oxidizedto the disulfide, cystamine
(2). The physiological role ofFMO is uncertain but itmay be
related to the formation ofdisulfide bonds during protein
synthesis (2). At least threedifferent forms of FMO exist in
rabbit (3-5). The cDNAsequence of rabbit lung and liver
document that they are differentgene products which are
related with 56% identity in aminoacid sequence (6). The
extrahepatic FMO is also present inrabbit kidney and bladder
andevidenceexistsforsex-anddevelopmental-related
differences. A recent studydemonstrated four different forms
of FMO, (IA1, IB1, IC1 and ID1)in human (7,8). The humanIB
FMO, present in small amounts inlung, liver and kidney, is
85% identical to the rabbitlung enzyme (8). Rabbit FMOs in
different tissuesmay be regulated independently andhave
different substrate specificities.Unlike the much studied
cytochrome P- 450 - dependentmonooxygenase system, mammalian FMO
is not inducible byexogenous compounds but doesappear to be
regulated developmently, presumablythrough alterations in88
hormonal status (9). Currentstudies in our laboratoryhave
shown that the levels of rabbitlung FMO duringpregnancy
increase at mid- and late-gestation,which correspond tothe
peak of progesterone andglucocorticoids, respectively,during
gestation. The FMO in kidneywas significantly increased
during late-, but notmid-gestation, suggestingthat FMO in
kidney is not influenced byprogesterone but may beregulated
by glucocorticoids whichpeak at the time ofparturition. The
purpose of this study is to examinethe effect of hormone
implantation to female rabbitsand hormone injectionto male
rabbits on FMO induction inrabbit tissues.89
MATERIALS AND METHODS
ANIMALS
Six female New Zealand whiterabbits were obtainedfrom the
Rabbit Research Instituteat Oregon State Universityand
housed in the Laboratory AnimalResource Center. Animalswere
maintained on a 12-hour day-nightcycle (7 AM- 7 PM), and
feeding was ad libitum.In order to follow theeffect of
hormone administration on FMO activityand protein levels, two
ALZET osmotic pumps (model 2001,flow rate 1 pl/hr for 7days)
were filled with propylene glycolfor controls, other two
pumps were filled with 0.208mg A-estradiol/m1 of propylene
glycol with 5% EtOH and 0.01%ascorbic acid (gives delivery
rate of 5 pg p-estradiol/day)
,and the other twopumps were
filled with 55 mg progesterone/mlof propylene glycol with 5%
EtOH (delivery rate of 1.3mg progesterone/day in 338 mOsmof
intraperitoneal fluid). Theywere implanted intraperitoneally
in rabbits, oneper each rabbit (10-12). Bloodsamples were
collected by heart puncture at0, 18, 42, 60, 90, and 114hour
after implantation. Plasmawas separated and kept at -20°C
until analyzed by radioimmunoassay.After final collection of
blood samples, animalswere euthanized by CO, asphxiation.The
tissues were immediatelyremoved and frozen in liquidnitrogen
andstoredat-90°Cuntilassayed.Hormoneswere
subcutaneously injected to malerabbits (about 3 kg each)for
5 days. Sunflower oilwas injected into 3 control rabbits,
dexamethasone (2 mg/kg/day)was injected into 4 rabbits,90
dexamethasone(2 mg/kg/day) was injectedinto 4rabbits,
progesterone(2mg/kg/day)wasinjected into3rabbits,
estradiol(20pg/kg/day)wasinjectedinto4rabbits,
aldosterone (20 pg/kg/day)was injected into 3 rabbits, and
estradiol(20 pg/kg/day)for 5 days then progesterone(2
mg/kg/day) for 5 days was injectedinto 3 rabbits.
RADIOINNUNOASSAY
The plasma levels ofprogesterone and estradiol from
rabbits were measured by radioimmunoassay(RIA) as decribed by
Sower and Schreck (13).
NICROSONE PREPARATION
Microsomes were prepared usinga modification of the
procedure of Guengerich (14).The levels of microsomal protein
were assayed by the method of Lowryet al. (15), using BSA'
as the standard.
4BSA, bovine serum albumin;SDS-PAGE, polyacrylamide gel
electrophoresis in the presence ofsodium dedocyl sulfate;
PBS, 20 mM potassium phosphate,pH 7.4, 0.8% NaCl; IgG,
immunoglobulin G; DMA, N,N'-dimethylaniline.91
IMMUNOQUANTITATION
The microsomal proteinswere resolved by SDS-PAGE andthen
electrophoretically transferredto nitrocellulose. Following
1 hour incubation at roomtemperature with 2% BSA inPBS, the
blots were stained with guineapig anti-rabbit lungFMO IgG
(20 lig IgG per ml in the 2%BSA-PBS buffer with 0.05%Triton
X-100) for 1.5 hour atroom temperature. The FMO-IgGcomplex
was visualized by incubating with[125I]-protein A for 1 hour
followed byautoradiography(16).Immunoquantitation was
performed by laser densitometryand relative amountsof FMO
were calculated utilizing thepurified rabbit lungFMO as
standard for lung and relativedensities ofblots were
compared for kidney.
ASSAY OF FMO ACTIVITY
The metabolism of ["C]-DMAby microsomal FMOwas performed
by HPLC to resolve the N-oxideand N-demethylated metabolites.
Microsomes (0.1 mg)or purified FMO (0.02 mg)were incubated
in 0.1 M tricine, pH8.5 containing 1 mM EDTA,and a NADPH
generating system [1 mMNADPH, 0.02 M isocitrate and1 Unit
isocitrate dehydrogenase].[14C)-DMA was added toa final
concentration of 0.5 mM (1-2pCiitimol).All components except
the microsomesor purified FMO were preincubatedfor 2 min and
the reaction initiated bythe addition ofenzyme. The reaction
was terminated by the additionof0.1 ml methanol. HPLC
analysis was performed witha Whatman RAC II Partisil 5ODS-392
(4.6 mm x 10 cm) column elutedwith 62% Me0H in waterat 0.5
ml/min. Metabolite quantitationwas performed with an on-line
radiochemical detector (BeckmanModel 171 with a solid cell).93
RESULTS AND DISCUSSION
There are several reportsdescribing induction ofFMO by
endogenous factors, includingsteroid hormones, ratherthan
exogenous chemicals. During lategestation, changes in the
hormonal milieu appear to beresponsible for inductionof FMO
inrabbitlung(3,17).Cortisol,throughitsdiurnal
secretion, may regulate thehepatic FMO activities infemale
mice (18). Diabetescan induce imipramine N-oxidationin mice,
an activity mediated exclusivelyby FMO (19).
The results of theradioimmunoassays showed thatboth
plasma progesterone and estradiollevels of hormonepump-
implanted female rabbitsbegan to increase at 60hours after
implantation and maintainedthe enhanced level untilkilled
(Figs. 3.1 and 3.2).Western blot analysis oflung microsomes
from the hormone pump-implantedfemale rabbits (114 hours
post-implantation), stained withguinea pig anti-rabbitlung
FMO IgG, shows that bothprogesterone and estradiol inducethe
lung FMO in female rabbits(Figs. 3.3 and 3.4). Inthe study
employingsubcutaneousinjectionwithdexamethasone,
progesterone,estradiol,aldosterone,orestradiolplus
progesterone to male rabbits,dexamethasone and progesterone
both significantly inducedlung FMO protein (Figs.3.5 and
3.6).DMA N-oxidase activitiesofboth progesterone and
dexamethasoneinjectedmalelungmicrosomeswerealso
significantly higher thanthat of control(Fig.3.7). Our
report reveals that thereare sex-related differences in94
induction ofFMO protein and activity in rabbitlung by
hormone administration. Estradiolinduced FMO in female but
not in male, whereas progesteroneinduced FMO in both maleand
female rabbit lung. Althoughthe route of administration,sex
and source of rabbitsare different, this result issupported
by several previous reportswhich showed sex differencesin
the concentration orenzyme activity of FMO in rats, mice,and
rabbits(20)and sex-related differencesin mouse liver
microsomal activity due totestosterone repression of the
liver enzyme(21,22). Rat liver FMO alsoappears to be
positivelyregulatedbytestosterone,whereasestradiol
exhibits repression of FMOlevels (9).
Western blot analysis of rabbitkidney microsomes stained
with guinea pig anti-rabbitlung FMO IgG has shown thatonly
dexamethasone induced FMO in kidney(Figs. 3.8 and 3.9). DMA
N-oxidase activity of microsomesfrom dexamethasone injected
rabbit kidney was significantlyhigher than that of control
(Fig. 3.10).
Another study in our laboratorycorrelated rabbit lung FMO
induction with respect to protein,enzyme activity, and mRNA
duringmid-andlate-gestationwithplasmalevelsof
progesterone and glucocorticoids whileglucocorticoid (but not
progesterone) levels correlated withFMO in kidney during
late-gestation (M.-Y. Lee et. al.).The results of this study
onhormone-implantedorinjectedrabbitsin which both
progesterone and dexamethasone inducedFMO in lung while only95
dexamethasone induced FMO in kidneycorrelate with the tissue-
specific hormonal regulationphenomena duringpregnancy in
rabbits. Since we only examinedfour hormones, other hormones
not used in our experimentmay regulate FMO. Some previous
reports support this differenthormonal regulation pattern in
different tissues. The hormonalregulation in lung and kidney
from mice and rats was differentfrom that in liver (22, 23).
Gestation increases FMO activityin rabbit lung (3, 17,24)
and in mouse placenta microsomes(25) but not in mouse liver
or lung.
The study discussed above indicatesthat FMO regulation is
under hormonal control, butthe effects observedappear to be
sex-, tissue-, and species-dependent.96
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Figure 3.1. Changes in plasmaprogesterone levels (mean ± SE)
of hormone pump implanted femaleNew Zealand white
rabbits. Each value representsthe mean of
duplicates from 2 differentanimals.EFFECT OF PROGESTERONE IMPLANTATION ONFEMALE RABBITS
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Figure 3.2. Changes in plasmaestradiol levels (mean ± SE)of
hormone pump implanted femaleNew Zealand white
rabbits. Each value representsthe mean of
duplicates from 2 different animals.,----.
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Figure 3.3. Western blot analysis oflung microsomes from
female rabbits 114 hours afterhormone pump
implantation (probed with antibodyto rabbit lung
FMO). Lane 1,2, control; lane3,4, estradiol; lane
5,6, progesterone. Each lane contained50 pg of
protein.Figure 3.3.
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Figure 3.4. Quantitation of FMO inlung microsomes from
progesterone or estradiol implantedfemale rabbits
114 hour post-implantation.The values shown
were obtained using densitometryfrom
autoradiograms of western blotsof 2 different
gels probed with antibodyto rabbit lung FMO.
Bars represent standarderror of the mean.Quantitation of Hormone Implanted FemaleRabbit Lung FMO
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Figure 3.5. Western blotanalysis of lung microsomesfrom
hormone injected male rabbitsprobed with antibody
to rabbit lung FMO. lanes1-3, 16-18, control;
lanes 4,19 (5.75 pmol),5,20 (8.63 pmol), 6,21
(11.5 pmol), purified rabbit lung FMO; lanes 7-10,
dexamethasone; lanes 11-13,progesterone; lanes
14,15,22,23, estradiol; lanes24-26, aldosterone;
lanes 27-29, estradiolplus progesterone. Each
lane contained 50pg protein except the purified
FMO standards.Figure 3.5.
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Figure 3.6. Quantitation oflung FMO from hormone injected
male rabbits. The valuesshown were obtained using
densitometry from autoradiogramsof western blots
(Fig.3.5) probed with antibodyto rabbit lung FMO.
Bars represent standarderror of the mean.
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Figure 3.7. "C-DimethylanilineN-oxidation by hormone injected
male rabbit lung microsomes.Each value represents
the mean of duplicateassays from 2 different
animals. Bars representstandard error of the
mean. (* * = P<0.05)111
Figure 3.8. Western blot analysisof hormone injected male
rabbit kidney microsomesprobed with antibody to
rabbit lung FMO. lanes1-3, 11-13, control; lanes
4-7, dexamethasone; lanes8-10, progesterone;
lanes 14-17, estradiol; lanes18-20, aldosterone;
lanes 21-23, estradiol plusprogesterone. Each
lane contained 50 pg protein.112
Figure 3.8.
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Figure 3.9. Quantitation of kidneyFMO from hormone injected
male rabbits. The values shownwere obtained using
densitometry from autoradiogramsof western blots
(Fig.3.8) probed with antibodyto rabbit lung FMO.
Bars represent standarderror of the mean.
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Figure 3.10. "C-DimethylanilineN-oxidation by kidney
microsomes from hormone injectedmale rabbits.
Each value represents themean of duplicate
assays from 2 different animals.Bars represent
standard error of themean.ec
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ABSTRACT
UnlikethemuchstudiedcytochromeP-450-dependent
monooxygenase system, mammlianmicrosomalFMO is not inducible
byxenobiotics,butdoesappeartoberegulated
developmentally, presumably throughalterations in hormonal
status. During the 31 day gestationalperiod of rabbit, the
level of progesterone linearlyincreases until mid- gestation
and then declines to originallevels by parturition, while
glucocorticoid levels peak onlyat parturition. It has been
shown that FMO is induced duringgestation in rabbit. In the
present study, maternal hepaticlevels of FMO have been
followed throughout gestation inpregnant rabbits by assaying
enzymeactivity,proteinlevels(westernblottingwith
antibody to pig liver FMO)and mRNA levels (northern blotting
with 32P-labeled rabbit liverFMO form 1 cDNA). The levelsof
FMO activity, protein andmRNA peak at both mid- andlate-
gestation. The early and latepeaks coincide with peaksof
plasma progesterone andglucocorticoids respectively, during
pregnancy.Subcutaneousinjectionwithdexamethasone,
progesterone,estradiol,aldosteroneorestradiolplus
progesterone to male rabbits,resulted in dexamethasone and
progesterone both significantlyinducing liver FMO mRNA.
Dexamethasone increased the yieldof total RNA two-fold
compared to controls. Thissuggests that the levels and
activity of hepatic FMOare regulated by endocrine factorsand
controlled by gene expression.122
INTRODUCTION
Mammalianflavin-containingmonooxygenase (FMO, EC
1.14.13.8) is a flavoprotein, whichcatalyzes the oxygenation
of a large variety of nitrogenand sulfur-containingdrugs and
xenobiotics (1). Most of themetabolites formed by thisenzyme
are biologically inactive andcan be easily excreted, however,
some arepotentially carcinogenicor mutagenic (1). The only
known endogenous substrate offlavin-containingmonooxygenase
is cysteamine, which isoxidized to the disulfide,cystamine.
The physiological role ofFMO is uncertain but itmay be
related to the formation ofdisulfide bonds during protein
synthesis (2). At least threedifferent forms of FMO existin
rabbit (3-5). Two liver FMOforms (I and II, whichare 54%
identical), have been characterizedin rabbit (4). Rabbit
liver form I is 87% identicalto the pig liverenzyme, but
only 56% identical to therabbit lung enzyme, confirmingthat
the rabbit liver and lungFMOs are distinctgene products
which evolved prior tospeciation. The lung form ofrabbit FMO
is also present in kidneyand bladder and evidence existsfor
sex- and developmental-relateddifferences. A recent study
demonstrated four different formsof FMO in humans (designated
by Philpot and Meyeras IA1, IB1, IC1 and ID1) (6,7). Human
IA1 is 87% identical to pig liverFMO and rabbit liver formI,
but surprisingly, is absentfrom adult human liver, butrather
is present in kidney.Human form IB1 is 85% identicalto
rabbit lung FMO and ispresent in small amounts inadult human123
lung, liver and kidney(7). The major form inadult human
liver is ID1, whichshares 85% identity to rabbitform II.
FMOs in different tissuesmay be regulated independentlyand
have markedly differentproperties, includingstability and
substrate specificity.FMO is not inducible byexogenous
compounds but is regulatedby endogenous factors likesteroid
hormones (8). Thereare several reports decribingregulation
of FMO by endogenousfactors, including steroidhormones,
rather thanexogenous chemicals.Duringlategestation,
changes in the hormonalmilieu appear to beresponsible for
induction of FMO in rabbitlung (3, 9). Anothercurrent study
in our laboratory,involving hormone implantationor injection
to rabbits, has shown thatboth progesterone anddexamethasone
induced FMO in male rabbitlung, whereas onlydexamethasone
induced FMO in kidney.Estradiol could induceFMO in female
rabbit lung but not inmale (M.-Y. Lee et.al.,unpublished).
Thepurposeofthepresentstudyistoexaminethe
developmental regulation ofFMO in maternal rabbit liverand
the effect of subcutaneouslyinjected hormones.124
MATERIALS AND METHODS
ANIMALS
Timed-pregnant New Zealand whiterabbits were obtained from
the Rabbit Research Instituteat Oregon State Universityand
housed in the Laboratory AnimalResource Center. Animalswere
maintained on a 12-hourday-night cycle and feedingwas ad
libitum. In order tofollow the developmentalregulation of
the levels of FMO activity,protein levels and mRNA,a total
of 20 pregnant, 2non-pregnant female and 2 malerabbits were
used. Two pregnant femaleswere euthanized on days 10, 15,20,
25, 28 and 31 of gestation.Following parturition, tworabbits
were euthanized on days 1, 7,21 and 28 post-partum. Animals
weresacrificedbyCO,asphxiation.Thetissueswere
immediately removed andfrozen in liquid nitrogenand stored
at -90°C until assayed.Hormones were subcutaneouslyinjected
into male rabbits (about3 kg each) for 5 daysas following:
sunfloweroilwasinjectedinto 3controlrabbits,
dexamethasone (2 mg/kg/day)into 4 rabbits, progesterone(2
mg/kg/day) into 3 rabbits,estradiol (20 µg /kg /day)into 4
rabbits, aldosterone (20pg /kg /day) into 3 rabbits, estradiol
(20 µg /kg /day) for 5 daysthen progesterone (2mg/kg/day) for
5 days was injected into3 rabbits.
MICROSOME PREPARATION
Microsomes were preparedusing a modificationof the
procedure of Guengerich (10).The levels of microsomalprotein125
were assayed by the method ofLowry et al. (11), using BSA5
as the standard.
IMMUNOQUANTITATION
The microsomal proteinswere resolved by SDS-PAGE and then
electrophoretically transferredto nitrocellulose. Following
an 1 hour incubation atroom temperature with 2% BSA inPBS,
the blots were stainedwith rabbit anti-pig liverFMO IgG (20
pg IgG per ml in the 2%BSA-PBS buffer with 0.05%Triton X-
100) for 1.5 hour atroom temperature. The FMO-IgGcomplexes
were visualized by incubating with[125I]-protein A (0.1 pCi/m1
in 2% BSA-PBS buffer)for one hour followed byautoradiography
(12). Immunoquantitationwas performed by laser densitometry
and relative densitiesof blots were compared.
'BSA, bovineserum albumin; SDS-PAGE, polyacrylamidegel electrophoresis in sodiumdedocyl sulfate; PBS, 20mM
potassium phosphate, pH7.4, 0.8% NaCl; DMA, N,N1-
dimethylaniline; IgG,immunoglobulin G; 20 XSSC, 3 M
sodium chloride, pH7.0, 0.3 M sodium citrate.126
ASSAY OF FMO ACTIVITY
The metabolism of [14C]-DMA bymicrosomal FMO was performed
by HPLC to resolve the N-oxideand N-demethylated metabolites.
Microsomes (0.1 mg)or purified FMO (0.02 mg) were incubated
in 0.1 M tricine, pH 8.5containing 1 mM EDTA, andan NADPH
generating system [1 mM NADPH,0.02 M isocitrate and 1 Unit
isocitrate dehydrogenase].[14C]-DMA was added toa final
concentration of 0.5 mM (1-2pCi/pM01). All components,
except the microsomesor purified FMO, were preincubatedfor
2 min and the reaction initiatedby the addition ofenzyme.
The reaction wasterminated by the additionof0.1ml
methanol. HPLC analysiswas performed with a Whatman RACII
Partisil 5 ODS-3 (4.6mm x 10 cm) column eluted with 62%Me0H
in water at 0.5 ml/min.Metabolite quantitationwas performed
with an on-line radiochemicaldetector (Beckman Model171
equiped with a solid cell).
RNA ISOLATION
Total RNA were prepared bythe modified method of acid
guanidinium thiocyanate-phenol-chloroformextraction (13).
RABBIT LIVER cDNA (1641 bp)PREPARATION
According to the rabbit livercDNA sequence done by Lawtonet
al. (14), the RBFMOH-Nsense (5'-TGTACGTCGGAGAACATGGCCAAGCGA-
3') and RBFMOH-C antisense(5'-AACTAGCAAATCTTTTACTTATAGG-3')
primers were used to amplifythe rabbit hepatic flavin-127
containingmonooxygenasecDNAproducedfromalibrary
generated from mRNA fromfemale rabbit liver at28 days
gestation. The resulting1641 by fragment, spanning from34 to
1674 (14) was cloned into theSmal site of pUC19 such thatthe
transcriptional orientation ofthe cDNA was the sameas that
of the lacZ gene in theplasmid. None of the isolatedclones
exhibited the predictedAvaII site at 1486 bp, althoughthey
did demonstrate theexpected pattern for allother enzymes
examined (4.33 kbp).
ELECTROPHORESIS AND TRANSFER
Electrophoresis of RNA throughagarose containing formaldehyde
was performed by published procedures(15). The amount of RNA
in each samplewas measured by optical density at260 and 280
nm; 20 pg was analyzed by electrophoresisin duplicate. RNA in
thegel was transferred tonylon membrane by capillary
movement overnight using20 X SSC buffer and the transferred
blot was exposed toUV (UV Crosslinker,XL-1000,Fisher
Biotech) light to fixthe RNA on the membrane (16).
HYBRIDIZATION
The probe, used to quantitaterabbit lung FMO mRNAon northern
blots, was obtained by randomprimer-labeling of rabbit liver
FMOformIcDNA(1641bp)witha 32P-dCTP(17).After
prehybridization for 4 h in6 X SSC, 50% formaldehyde,0.1%
SDS, 5 X Denhardt's solution,100 µg /ml salmonsperm DNA and128
100 µg /m1 tRNA, hybridizationwas performed at 420C overnight
in the same medium in thepresence of cDNA labeled with [a-
32P]dCTP (ICN) by a random primer-labelingkit from Boehringer
Mannheim. The filter was washed in2 X SSC buffer containing
0.1% SDS twice at room temperature for15 min and 0.1 X SSC
buffer with 0.1% SDS at room temperaturefor 15 min. The
membrane was then exposed to KodakX-OMAT AR film (Kodak,
Rochester, NY) for 3 days with an amplifyingscreen at -90°C.
Integrity of RNA was routinely assessed witha 32P 0-actin cDNA
probe to demonstrate that each lanecontained approximately
equal amounts of RNA.129
RESULTS AND DISCUSSION
Little work has been publishedon the effects of the
hormonal regulation of FMO. Sex-relateddifferences in the
concentration or enzyme activity ofFMO have been observed in
rats, mice, and rabbits (18). Duringlate gestation, changes
in the hormonal milieuappear to be responsible for FMO
induction in rabbit lung(3,9). A current study inour
laboratory, involving regulation ofFMO throughout gestation
in rabbit lung and kidney,indicates that mid- and late-
gestation peaks of FMO inductionin lung correlate to the
peaksofplasmaconcentrationsofprogesteroneand
glucocorticoids, respectively. Theonly peak of kidney FMO
induction occurs in late gestation,consistent with plasma
glucocorticoidslevelduring pregnancy(19,Leeet.al.,
unpublished).Anothercurrentstudyinourlaboratory,
involving hormone implantationor injection supports these
results; both progesterone anddexamethasone induced FMO in
male rabbit lung, whereas, onlydexamethasone induced FMO in
male rabbit kidney. Estradiol couldalso induce FMO in female
rabbit lung but not in males(Lee et.al. unpublished).
The regulation of rabbit FMOthroughout gestation and
postpartum has been followed inmaternal liver utilizing
immunoquantitation with antibodyto pig liver FMO, DMA N-
oxidation activity, and northernblotting using a 32P-labelled
rabbit liver FMO form I cDNAprobe. The level of hepatic FMO
was significantly elevated at the earliestgestational time130
point examined (day 10) andthe peak levels of proteinfrom
western blot analysis were observedat mid- and late-gestation
(Figs.4.1,4.2).The levels of liver FMO formI mRNA,
quantitated by northern blottingusing 32P- labelled rabbit
liver FMO form I cDNA,significantly increased throughout
gestation and two peakswere observed at mid- and late-
gestation (Figs.4.3, 4.4). DMA N-oxidase activitieswere
elevated throughoutpregnancy with peaks at mid- and late-
gestation (Fig. 4.5). Thesemid- and late-gestationpeaks in
FMO protein, activityand mRNA expression correlateto levels
of plasma progesterone andglucocorticoids duringpregnancy
(Fig. 4.6). Rabbit liverFMO is higher in non-pregnantfemale
rabbits compared to malesas determined by protein levels,
activity, and mRNA expression(Figs. 4.2, 4.4, 4.5). Astudy
ofsubcutaneoushormoneinjectionwithdexamethasone,
progesterone,estradiol,aldosterone,orestradiolplus
progesterone to male rabbitsshowed that dexamethasoneand
progesterone both significantlyinduced hepatic FMO mRNA and
dexamethasone increased the yieldof total RNA two-fold
compared to controls (Figs.4.7-4.9). The studies discussed
above indicate that rabbitliver FMO, like lung and kidney
FMO, is regulated byprogesterone and glucocorticoids during
gestation. These findingsare not in agreement with a previous
study which reported thatFMO activity (as determined byDMA-
N-oxide formation) didnot increase during late gestationin
rabbit liver microsomes(9).The results presentedhere131
confirm the role of hormonalregulation in the control of
hepatic FMO, but the effectsappear to be sex- and tissue-
specific.132
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Figure 4.1. Western blot analysis of rabbitliver microsomes
throughout gestation probed with antibodyto pig
liver FMO. lane 1, male; lane 2,nonpregnant
female; lane 3, 10 day; lane 4, 15 day; lane5, 20
day; lane 6, 25 day; lane 7, 28 day; lane8, 31
day of pregnancy; lane 9, 1 day postpartum;lane
10, 7 day postpartum; lane 11, 21 daypostpartum;
lane 12, 29 day postpartum. Each lane contained50
pg protein.134
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Figure 4.2. Quantitation of rabbitliver FMO duringpregnancy.
The values shown were obtainedusing densitometry
from autoradiograms of westernblots of 2
different gels (fig.4.1) probedwith antibody to
pig liver FMO. Bars representstandard error of
the mean. (* * = P<0.05)QUANTITATION OF RABBIT LIVER FMO DURING PREGNANCY
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Figure 4.3. Northern blot analysisof rabbit liver total RNA
throughout gestation probed with"P-labelled
rabbit liver FMO form I cDNA.lane 1, male; lane
2, nonpregnant female; lane 3,10 day; lane 4, 15
day; lane 5, 20 day; lane 6,25 day; lane 7, 28
day; lane 8, 31 day ofpregnancy; lane 9, 1 day
postpartum; lane 10, 7 day postpartum;lane 11, 21
day postpartum; lane 12, 29 daypostpartum. Each
lane contained 50 pg RNA. Theblot was
subsequently reprobed witha "P-labeled human
fibroblasta -actin cDNA to assess the relative
amounts of RNA analyzed in eachsample.138
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Figure 4.4. Rabbit liverFMO mRNA expression measured witha
rabbit liver FMO cDNA probethroughout gestation.
The graph was produced usingdensitometry from
autoradiograms of northern blotsof Figure 4.3.RABBIT LIVER FMO mRNAEXPRESSION DURING PREGNANCY
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Figure 4.5. "C-DimethylanilineN-oxidation by rabbit liver
microsomes throughout gestation.Each value
represents the mean of duplicateassays of 2
different animals.N,NDMA oxidation by rabbit liver microsomes during pregnancy
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Figure 4.6. Peripheral plasma levelsof progesterone, cortisol
and corticosterone in rabbit duringpregnancy.
This graph was adapted from Baldwinet al. (1974)
(19).Plasma hormone levels In pregnant rabbits
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Figure 4.7. Northern blot analysis of hormone injected male
rabbit liver total RNA probed with 32P-labelled
rabbit liver FMO form I cDNA. lanes 1-3, control;
lanes 4-7, dexamethasone; lanes 8,9, progesterone;
lanes 10-13, estradiol; lanes 14-16, aldosterone;
lanes 17,19, estradiol plusprogesterone. Each
lane contained 20 pg total RNA. The blot was
subsequently reprobed with a 32P-labeled human
fibroblast 0-actin cDNA to assess the relative
amounts of RNA analyzed in each sample.Figure 4.7.
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Figure 4.8. Hormone injected male rabbitliver FMO mRNA
expression with rabbit liver FMO formI cDNA
probe. The graph was produced using densitometry
from autoradiograms of northern blots fromfigure
4.7. Bars represent standarderror of the mean.
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Figure 4.9. Yields of total RNA in hormoneinjected male
rabbit livers as determined byA260using
spectrophotometer.YIELDS OF TOTAL RNA IN HORMONE TREATEDRABBIT LIVERS
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ABSTRACT
Thediurnalvariationofrabbitflavin-containing
monooxygenase (FMO) was examined in lung andkidney. Levels of
protein and mRNA as wellas enzymatic activity in rabbit lung
were quantified in groups of two femalerabbits sacrificed at
4 AM, 8 AM, 12 noon, 4 PM, 8PM and 12 midnight. In general,
there was good agreement betweenFMO proteins, activities and
mRNA levels at the various timepoints examined with minimum
values at 8 PM and maximumvalues at 12 noon. A similar
diurnal variation also existsin the kidney, but thepattern
differs in degree. We speculatethat the observed fluctuations
in FMO levels with time ofday may be correlated withprotein
regulation by the endogenousfactors like hormones.156
INTRODUCTION
Flavin-containingmonooxygenase(FMO)catalyzesthe
oxygenation of a wide varietyof foreign compounds bearing
nucleophilic nitrogenor sulfur functional groups. Whilemost
ofthemetabolitesformedbythisenzymerepresent
detoxification reactions,some are potentially carcinogenic
and mutagenic (1).Unlike the cytochromeP450 dependent
mixed-function oxidase system,whose levels and associated
enzyme activities can be regulatedby exogenous factors such
as drugs, environmental pollutants,synthetic steroids and
food components, FMO levelsappear to be governed solely by
endogenous factors suchas hormones.
FMO levels in rat andmouse liver appear to be regulated by
steroid sex hormones(2-4). Sex differences havealso been
observed in rabbits (5,6).During late gestation in rabbit,
FMO in lung increases inapparent correlation with plasma
progesterone levels (M.-Y. Lee et.al. unpublished). Diabetes
has been shown to increaseFMO catalyzed imipramineN-
oxidation in mice (7).
Hormonal changes in cortisollevels, which vary diurnally,
have been postulated to regulatehepatic FMO levels in female
mice (8). To our knowledge,diurnal changes in extrahepatic
levels of FM0 have not beenexamined.
Rabbit lung FMO has been purifiedby Williams gt al., and
Tynes et al. (9,10). Theenzyme was found to be catalytically
and immunologically distinctfrom that found in liver.Recent157
sequencing of the corresponding cDNAs confirmedthis finding
(11). As part of ongoing efforts in thislaboratory to further
characterize the pulmonary form ofrabbit FMO,we have
examined the diurnal variation ofthe enzyme in lung and
kidney of female New Zealand Whiterabbits.158
MATERIALS AND METHODS
ANIMALS
Twelve New Zealand white female rabbitswere obtained from
the Rabbit Research Institute atOregon State University and
housed in the Laboratory AnimalResource Center. Animals were
maintained on a 12-hour day-nightcycle(7 AM-7 PM), and
feeding was ad libitum. In orderto follow the short term
diurnal variation of the levelsof FMO activity, protein and
mRNA, two animals were killed at4 AM, 8 AM, 12 noon, 4 PM, 8
PM and 12 midnight. Animalswere killed by CO2 asphxiation.
The tissues were immediatelyremoved and frozen in liquid
nitrogen and stored at -90°C untilassayed.
MICROSOME PREPARATION
Microsomes were prepared usinga modification of the
procedure of Guengerich (12). Thelevels of microsomal protein
were assayed by the method of Lowry et al.(13) using BSA6 as
the standard.
6BSA, bovine serum albumin;SDS-PAGE, polyacrylamide gel
electrophoresis in thepresence of sodium dodecyl sulfate;
PBS, 20 mM potassium phosphate,pH 7.4, 0.8% NaCl; IgG,
immunoglobulin G; DMA, N,N'-dimethylaniline;DTNB, 5,5'-
dithiobis (2-nitrobenzoic acid);TNB, 2-nitro-5-
thiobenzoic acid.159
IMMUNOQUANTITATION
The microsomal proteinswere resolved by SDS-PAGE and then
electrophoretically transferred tonitrocellulose. Following
an 1 hour incubation atroom temperature with 2% BSA in PBS,
the blots were stained with eitherguinea pig anti-rabbit lung
FMO IgG or rabbit anti-pig liverFMO IgG (20 pg IgGper ml in
the 2% BSA-PBS buffer with 0.05%Triton X-100) for 1.5 hourat
room temperature. The FMO-IgG complexswere visualized by
incubating with [125I]-proteinA (0.1 pCi/m1 in 2% BSA-PBS
buffer)for1hourfollowedbyautoradiography(14).
Immunoquantitation was performed bylaser densitometry. The
relative amounts of FMOwere calculated utilizing the purified
rabbit lung FMOas standard for lung and relative densitiesof
blots were compared for liver.
ASSAY OF FMO ACTIVITY
1.160 -DMA metabolismassay.
The metabolism of ["C]-DMA bymicrosomal FMO was performed
by HPLC to resolve the N-oxide andN-demethylated metabolites.
Microsomes (0.1 mg)or purified FMO (0.02 mg) were incubated
in 0.1 M tricine,pH 8.5 containing 1 mM EDTA, anda NADPH
generating system [1 mM NADPH,0.02 M isocitrate and 1 Unit
isocitrate dehydrogenase].["C]-N,N-DMA was added toa final
concentration of 0.5 mM (1-2pCi/gmol). All components,
except the microsomesor purified FMO, were preincubated for
2 min and the reaction initiatedby the addition ofenzyme.160
The reaction was terminatedby the addition of0.1 ml
methanol. HPLC analysiswas performed with a Whatman RAC II
Partisil 5 ODS-3 (4.6mm x 10 cm) column eluted with 62%Me0H
in water at 0.5 ml/min. Metabolitequantitation was performed
with an on-line radiochemicaldetector (Beckman Model 171
equiped with a solid cell).
2. Methimazole S-oxidationassay.
The assay was performed by theprocedure of Dixit and Roche
(8). Final assay concentrationswere 0.1 M tricine, 1.0 mM
EDTA, 60 gM DTNB, 6.0 mM KPi,0.025 mM DTT, 0.1 mM NADPH, and
1.0 mM methimazole.0.5 ml buffer,H20,microsomes(0.25
mg/ml),and NADPH were added toa1m1 cuvette. After 40
seconds, 10 gl DTT and 60 glDTNB in KPi were added. About 60%
of DTNB will react with residualDTT to yield TNB havingan
absorbance of about 0.6 at412 nm. After at least 2 minto
prewarm to 37°C, the reactionwas initiated by addition of 10
gl methimazole. The rate ofreaction was compared withthat of
anidenticalmixtureinthesecondcuvettelacking
methimazole. The absorbancewas measured at 412 nm. Note:e
forTNB=28,200/M/cm,two moleculesofTNB(nitro-5-
thiobenzoate) are consumedper molecule product formed.
RNA ISOLATION
Total RNA were prepared bythe modified method of acid
guanidinium thiocyanate-phenol-chloroformextraction (15).161
ELECTROPHORESIS AND TRANSFER
Electrophoresis of RNA throughagarose containing formaldehyde
was performed by published procedures (16). Theamount of RNA
in each sample was measured by opticaldensity at 260 and 280
nm; 20 Ag was analyzed by electrophoresis in duplicate.RNA in
thegel was transferred to nylonmembrane by capillary
movement overnight using 20 X SSC bufferand the transferred
blot was exposed to UV(UV Crosslinker,XL-1000,Fisher
Biotech) light to fix the RNAon the membrane (17).
HYBRIDIZATION
The probe, used to quantitate rabbitlung FMO mRNA on northern
blots, was obtained by random primer-labelingof rabbit lung
FMO cDNA (1643 bp)(generously provided by Dr. R. N. Hines)
with a 32P -dCTP(18). After prehybridization for 4hour in 6
X SSC, 50% formaldehyde, 0.1%SDS, 5 X Denhardt's solution,
100 Ag/ml salmon sperm DNA and 100pg /ml tRNA, hydbidization
was performed at 42 °C overnight in thesame medium in the
presence of cDNA labeled with [a- 32P]dCTP(ICN) by a random
primer-labeling kit from BoehringerMannheim. The filter was
washed in 2 X SSC buffer containing0.1% SDS twice atroom
temperature for 15 min and 0.1 XSSC buffer with 0.1% SDS at
room temperature for 15 min. The membranewas then exposed to
Kodak X-OMAT AR film (Kodak, Rochester,NY) for 6 days with an
amplifying screen at -90°C.Integrity of RNA was routinely
assessed with a 32P-labeled A-actincDNA probe to demonstrate162
that each lane contained approximately equalamount of RNA.163
RESULTS
The diurnal variation of FMO in lungand kidney of female
New Zealand White rabbits has been determinedby 1) assaying
the microsomes for enzymatic activity("C-DMA N-oxidation, S-
methimazole oxidation), 2) immunoquantitationof levels of FMO
by western blotting and 3) quantitationof mRNA by northern
blot analysis.
Immunoquantified lung FMO protein levelsrose from 4 AM to
highest levels of 1203 ± 2.0 and1265 ± 155 pmols/mg protein
at 8 AM and 12 noon, respectively.This specific contents
correspond to about 8% (by weight) ofthe total microsomal
protein. Protein levels decreased totheir lowest values at 8
PM (Figs. 5.1 and 5.2) with a total variationbetween highest
and lowest values 2.5 fold. The levelof pulmonary FMO mRNA
quantitated by northern blotting using32P-labeled rabbit lung
FMO cDNA similarly increased from 4AM but did not reach a
maximum level until 4 PM. An apparent rapiddecline in mRNA
levels occurred so that lowest levelswere reached at 8 PM,
similar to western blot results (Figs.5.3 and 5.4). DMA N-
oxidase activity in lung microsomes(Fig.5.5) correlated
reasonably well with western blot resultsshowing peak values
at noon(7.0±0.75 nmols N,N-DMA-Oxide produced/min/mg
protein) and exhibited lowest activityat 8 PM (3.28 ± 0.31
nmol/min/mg). Methimazole S-oxidationactivity (Fig. 5.6) of
lung microsome reflected DMA N-oxidaseactivity with the
highest activity observed at 12noon (1.16 ±0.21 nmols164
methimazole oxidized/min/mg protein) andlowest at 8 PM (0.61
± 0.11 nmol/min/mg).
Because of variability in the data and the lowlevels of
protein observed, no significant diurnalvariation in FMO
levels could be ascertained in kidney (Figs.5.7-5.10).165
DISCUSSION
Results presented here provide evidence fora diurnal
variation in rabbit lung FMO protein. Maximum valuesare
reached at approximately 12 noon and minimum valuesare found
at8PM.A diurnal variationin hepaticFMO has been
documentedinfed and starvedfemale mice with highest
activity observed in animals sacrificed betweem4 and 5 PM
compared to8to9AM(8).This is the reverse of our
observations(i.e.levels at 8 AM were higher than levels
observed at4PM)in rabbit lung and kidney. This is not
surprising since the presumed hormonal regulationof FMO
activity observed during the estrous cycle andpregnancy has
been found to be species- and tissue-dependent(5,6,20).
Rabbit liver FMO does not vary substantially withtime of day
(unpublished results, this laboratory). Levels ofmRNA were
largely consistent with FMO levels and enzymatic activity,but
a noticeable disparity exists at the 4 PM time point where
levels and activity are definitely declining whilemRNA levels
are peaking. The reason for this is unknown, but it is likely
that a lag in degradation is not occurring.
The magnitude in variation of FMO levels observed diurnally
issmall(approximately 0.8nmol/mgproteinversus
approximately 5 nmol/mg) relative to that observed during
pregnancy (6). It is unknown whether the large increase in FMO
levels during late gestation overrides diurnal variationor
levels continue to fluctuate at this stage with timeof day.166
Data on diurnal variation of hormones in rabbitare scant
and it would be difficult to speculateon specific hormones
responsibleforinducing or repressing effectsobserved.
Testosteroneisapparentlyresponsibleforsexrelated
differences in the liver enzyme in miceacting to repress
microsomal activity(2,3).Rat liver FMO is repressed by
estradiolandappearstobepositivelyregulatedby
testosterone (19). Gestation is known toalter FMO levels.
Specifically rabbit lung FMO andmouse placental FMOis
stronglyinducedduringpregnancy(5,6,20).A20-fold
induction of DMA N-oxidation is observedin the pig corpora
lutea during the estrous cycle (21).Further evidence for
hormone regulation of FMO was recently providedin experiments
with hypophysectomized male andfemale rats (22). FMO activity
was reduced in male liver yet showedno effect or was even
stimulated in female liver. Tissuedependence was exhibited by
the fact that FMO enzymatic activityincreased 3-fold in
kidney of males, yet decreased inlung in both sexes.
The disulfide-sulfhydryl ratio of rathepatic tissue has
been found to vary diurnally. This alteringratio has been
speculated to represent a regulatory mechanismin that many
enzymaticactivitiesareeithersulfhydrylor disulfide
dependent(23).Cysteamineis the only known endogenous
substrate for FMO and oxidation takesplace to form the
disulfide cystamine(24).Ziegler has proposed that FMO
catalyzed formation of cystaminemay represent a significant167
source of cellular disulfides (24) which theoreticallycould
alterthisratioandthereforebeinvolvedinenzyme
regulation. However, FMO levels in all tissuesexamined have
been found to be in much higher concentrationsthan the
substrate cysteamine. The reaction wouldtherefore likely be
limited by the availabilty ofsubstrate. Further studies on
the mechanisms regulating the rate of cysteaminesynthesis are
needed before further speculationson the possbile involvement
of FMO on enzyme regulationare made.
It was confirmed that FMO is under long-termcontrol of
hormones throughout gestation(Lee et.al.,unpublished).
Progesterone, dexamethasone, and estradiolwere involved in
the induction of FMO at the level ofgene expression during
gestation. While short-term diurnal variationof liver FMO is
related to the variation of gluconeogenesisstatus (8), the
mechanism of diurnal variation of extrahepaticFMO would be
different. Dixit and Roche (1984)have shown that cortisol
controls hepatic FMO activities in femalemice through its
diurnalvariation.Glucocorticoids whichinvolveinthe
glucose metabolism in hepatic tissue,may involve in short-
term regulation of FMO in extrahepatic tissue.The data from
thisstudyindicatethatthereisshort-termbimodel
regulation of FMO in rabbit lung whereasthe diurnal variation
in kidney is negligible.168
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Figure 5.1. Western blot analysis of rabbitlung microsomes
from 4 am to 12 midnight. Tissueswere probed with
antibody to rabbit lung FMO. lanes 1-2,4 am;
lanes 3-4, 8 am; lanes 5-6, 12 noon; lanes7-8, 4
pm; lanes 9-10, 8 pm; lanes 11-12, 12 midnight;
lanes 13-15, purified rabbit lung FMO, 5.75pmol,
8.63 pmol, 11.5 pmol. Each lane contained 50pg
protein except FMO standards.Figure 5.1.
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Figure 5.2. Quantitation of rabbit lungFMO from 4 am to 12
midnight. The values shown were obtainedusing
densitometry from autoradiograms of westernblots
probed with antibody to rabbit lungFMO.
* * represents the statistical difference (P<0.05)
when comparing the value of 8pm with others.2000
Diurnal Variation of Rabbit Lung FMO Protein
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Figure 5.3. Northern blot analysisof rabbit lung total RNA
from 4 am to 12 midnight. RNAwas probed with 32P-
labelled rabbit lung FMO cDNA. lane1, 4 am; lane
2, 8 am; lane 3, 12 noon; lane 4, 4pm; lane 5, 8
pm; lane 6, 12 midnight. Each lane contained 20pg
total RNA. The blot was subsequentlyreprobed with
a "P-labeled human fibroblast 0-actin cDNA to
assess the relative amounts of RNA analyzed in
each sample.Figure 5.3.
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Figure 5.4. Rabbit lung FMO mRNA expressiondetermined with
rabbit lung FMO cDNA from 4am to 12 midnight. The
graph was produced using densitometry from
northern blots in figure 5.3.60
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Figure 5.5. 141C-N,N-DimethylanilineN-oxidation by rabbit lung
microsomes from 4 am to 12 midnight.Each value
represents the mean of 2 assay replicationsfrom
the same preparations of 2 differentanimals.
* * represents the statistical difference(P<0.05)
when comparing the value of 8pm with others.10
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Figure 5.6. Methimazole S-oxidation by rabbitlung microsomes
from 4 am to 12 midnight. Each value represents
the mean of 2 assay replications from thesame
preparations of 2 different animals.
* * represents the statistical difference (P<0.05)
when comparing the value of 8 pm with others.2.000
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Methimazole SOxidation by rabbit lung microsome
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Figure 5.7. Western blot analysis of rabbit kidney microsomes
from 4 am to 12 midnight. Tissues were probed with
antibody to rabbit lung FMO. lanes 1-2, 4 am;
lanes 3-4, 8 am; lanes 5-6, 12 noon; lanes 7-8, 4
pm; lanes 9-10, 8 pm; lanes 11-12, 12 midnight.
Each lane contained 50 pg protein.Figure 5.7.
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Figure 5.8. Quantitation of FMO in rabbit kidney from4 am to
12 midnight. The values shown were obtained using
densitometry from autoradiograms of western blots
probed with antibody to rabbit lung FMO.3E4
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Figure 5.9. 14C-N,N-Dimethylaniline N-oxidation by rabbit
kidney microsomes from 4 am to 12 midnight. Each
value represents the mean of 2 assays of different
animals.1.500
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Figure 5.10. Methimazole S-oxidation by rabbitkidney
microsomes from 4am to 12 midnight. Each value
represents the mean of 2 assays of different
animals.2.000
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